"Blood" is one of the series of textbooks by WHO blood safety department to support the global strategy for blood safety and the preparation of the. In 1994, WHO published a book "blood and blood product safety", this material specialized engaged in blood donation mobilization, selected blood donors, blood, blood separation and preparation and distribution of blood collection agencies and staff health laboratory and hospital blood bank write. This material is composed of four volumes: Introduction: blood transfusion safety guidelines and principles of Volume 1: safe blood second volumes: screening of HIV and other infectious pathogens: third copies of blood group serology of this set of textbooks in many countries in the world for application, training and on-the-job training, as well as the distance education and training. "Establish blood safety distance education project: Published in 1998 by WHO blood safety in the project coordinator guide". This book is the hope to use this material provides guidance to carry out distance education project of the national blood safety. "" "blood for clinical use of blood for clinical use is" WHO blood safety following the textbook compiling teaching materials, mainly discusses the clinical aspects of blood transfusion. Teaching aims to tell the reader how the medical institutions at all levelsProper application of blood products without affecting its quality and safety standards. The textbook includes two parts: the textbook: used for education and training programs, or can be used for clinical and blood transfusion worker self-study; Manual: use in clinical work. Textbook: textbook includes a system and how to apply knowledge of blood and blood products, especially how to minimize unnecessary blood transfusions. The book is divided into three parts. The first part: principles, products, operating procedures; the second part: clinical transfusion practice; the third part: the reasonable application of blood: for practice.
The first part thanks the translator order principle, products and operating procedures of 1 rational use of blood and blood products 1.1 reasonable and unreasonable transfusion of blood safety in 1.3 of 1.2 clinical blood use the 1.4 necessary conditions for clinical transfusion practice principle 2 blood, oxygen and cycle 2.1 fluids and blood supply of the body gap 2.2 2.3 3 3.1 3.2 anemia hemoglobin concentration and red blood cell hematocrit detection of 3.3 clinical value of anemia in 3.4 hemoglobin value interpretation 3.5 anemia anemia in 3.6 to 3.7 acute blood loss anemia of chronic blood loss anemia caused by 3.8 3.9 other causes of chronic anemia in 3.10 anemia treatment principle 3.11 anemia prevention principle 4 alternative solution 4.1 definition 4.2 intravenous fluid therapy 4.3 vein alternative solution 4.4 the rehydration way 4.5 replacement fluid characteristics of 5 blood products 5.1 5.2 5.3 blood components defined blood 5.4 apheresis separating and collecting blood component products 5.5 plasma protein products (plasma fractionation) 5.6 blood products: characteristics of 6 clinical blood transfusion. The order of 6.1 at the right time to correct blood transfusion to correct in 6.2 blood products for the 6.3 red cells with test (crossover) side effects of 6.4 before blood transfusion for 6.5 before transfusion of blood products storage 6.6 blood products transfusion monitoring infusion of 6.7 patients with 6.8 special program 7 7.1 blood transfusion reaction of 7.2 early treatment measures and the investigation and analysis of 7.3 acute transfusion reaction 7.4 delayed complications of blood transfusion: necessity of clinical decision evaluation of transfusion transmitted diseases 8.1 7.5 other delayed complications of blood transfusion of 7.6 massive blood transfusion second part clinical transfusion practice 8 transfusion 8.2 identified lack of need for transfusion 9 Department of internal medicine 9.1 anemia in 9.2 ferric heme 9.3 hemolytic anemia in 9.4 malaria 9.5 HIV/AIDS (human immunodeficiency virus / HIV) in 9.6 glucose -6- phosphate dehydrogenase (G6PD) genetic disease lack of 9.7 bone marrow failure in 9.8 hemoglobin of 9.9 hemorrhagic disease and blood transfusion in 9.10 congenital hemorrhagic and thrombotic disease 9.11 acquired hemorrhagic and thrombotic disease 10. Section 10.1 pregnancy physiological and hematological changes in 10.2 pregnant women with chronic anemia in 10.3 obstetric hemorrhage in 10.4 newborn hemolytic disease (HDN) of 11 pediatric and neonatal anemia in children 11.1 children 11.2 anemia treatment 11.3 special clinical situations of blood transfusion in 11.4 hemorrhagic and thrombotic disease 11.5 thrombocytopenia in 11.6 of 12 neonatal transfusion surgery and anesthesia in 12.1 patients to choose and prepare 12.2 and reduce blood loss in the operation techniques of the 12.3 liquid supplement and blood transfusion of autologous blood transfusion after operation 12.4 12.5 13 trauma and emergency surgery 13.1 emergency surgery or trauma patients treated 13.2 early assessment and resuscitation of 13.3 re evaluation of 13.4 final 13.5 low blood volume of other causes in 13.6 pediatric patients with 14 burn in 14.1 burn patients treated 14.2 burn severity 14.3 burn patients with fluid resuscitation in 14.4 burn patients treated 14.5 burn prevention to third part of blood: for reasonable application practice 15: what can I do? 15.1 from the start where 15.2 action planning committee of blood transfusion in 15.3 Hospital of the 15.4 clinical blood use guide 15.5 blood for clinical use is the education and training of vocabulary
Book review on "the Universal Copyright Convention" the provisions of article second, WHO publications, copyright protection. To obtain WHO publication of part or all of the rights of reproduction or translation, should apply to the Office published WHO in Switzerland Geneva. WHO welcome such application. The name and the presentation of material used in this book, do not represent the WHO Secretariat on any state, territory, city or area or its authority, or legal status on the border or boundary delineation of any opinion. The book mentioned some Professional Company or some manufacturing firms products, does not mean they are compared with similar products of other companies or not mentioned, has become an approved or recommended by the WHO. In order to avoid the mistake and omission, the first letter of patent products use capital letters to show the difference between.
According to the "world copyright convention" the provisions of article second, WHO publications, copyright protection. To obtain WHO publication of part or all of the rights of reproduction or translation, should apply to the Office published WHO in Switzerland Geneva. WHO welcome such application. "Name and the presentation of material" the blood for clinical use, does not represent the WHO Secretariat on any state, territory, city or area or its authority, or legal status on the border or boundary delineation of any opinion. "The clinical use of blood" refer to some Professional Company or some manufacturing firms products, does not mean they are compared with similar products of other companies or not mentioned, has become an approved or recommended by the WHO. In order to avoid the mistake and omission, the first letter of patent products use capital letters to show the difference between.
Medical Science @ 2017